Merck (NYSE:MRK) has agreed to acquire Terns Pharmaceuticals in a deal aimed at expanding its oncology and hematology ...

Indiana University cancer specialists just helped put Indianapolis on the global oncology map, serving as authors and ...

TAMPA, Fla., April 7, 2026 /PRNewswire/ -- TuHURA Biosciences, Inc. (NASDAQ:HURA) ("TuHURA" or the "Company"), a Phase 3 immuno-oncology company developing novel therapeutics to overcome resistance to ...

Detailed price information for Corbus Pharmaceuticals Hldgs Inc (CRBP-Q) from The Globe and Mail including charting and trades.

CytomX Therapeutics, Inc. (NASDAQ:CTMX) is one of the best multibagger penny stocks to invest in. On March 23, analysts at ...

FDA feedback enables Corbus to proceed with proposed registrational study design and endpoints to support potential accelerated approval in ...

While RMC is resistant to many common treatments, specific protocols have shown efficacy. Platinum-based chemotherapy remains ...

Stifel on Tuesday initiated coverage of Summit Therapeutics Inc. SMMT, citing the potential of its lead drug candidate, ...

Researchers from the Indiana University Melvin and Bren Simon Comprehensive Cancer Center are part of an international team ...

Mrs. Garofalo brings over 20 years of experience in Phase I-IV drug and biologic development TAMPA, Fla., April 7, 2026 /PRNewswire/ -- TuHURA Biosciences, Inc. (NASDAQ:HURA) ...

For most patients diagnosed with kidney cancer, the standard playbook is clear. Immunotherapy and targeted therapies directed ...